Phase 0 1 trial
Phase 0
NCT01913119 Jul 2013 extranodal nasal NK/T cell lymphoma Samsung Medical Center
Completed
No outcome recorded
Phase 1 34 trials
Phase 1
NCT06963346 Jun 2025 → Apr 2028 urinary bladder cancer H. Lee Moffitt Cancer Center and Research Institute
Suspended
No outcome recorded
Phase 1
NCT05230368 Dec 2022 → Dec 2025 immunodeficiency 132b ANRS, Emerging Infectious Diseases
Completed
No outcome recorded
Phase 1
NCT04639843 Nov 2022 adult T-cell leukemia/lymphoma , enteropathy-associated T-cell lymphoma , extranodal nasal NK/T cell lymphoma , hepatosplenic T-cell lymphoma +1 National Cancer Institute (NCI)
Withdrawn
No outcome recorded
Phase 1
NCT04774068 Sep 2021 → Oct 2024 anaplastic large cell lymphoma , mycosis fungoides variant Walter Hanel
Completed
No outcome recorded
Phase 1
NCT04447027 Dec 2020 → Jul 2024 peripheral T-cell lymphoma, not otherwise specified , primary cutaneous T-cell lymphoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT04233697 Feb 2020 → Jul 2022 T-cell non-Hodgkin lymphoma Columbia University
Withdrawn
No outcome recorded
Phase 1
NCT03432741 Mar 2018 → Aug 2022 Hodgkins lymphoma , breast adenocarcinoma , mycosis fungoides , nodal marginal zone B-cell lymphoma Mayo Clinic
Terminated
No outcome recorded
Phase 1
NCT02512497 Dec 2017 → Oct 2023 T-cell large granular lymphocyte leukemia , T-cell prolymphocytic leukemia , peripheral T-cell lymphoma, not otherwise specified , primary cutaneous T-cell lymphoma Ohio State University Comprehensive Cancer Center
Completed
No outcome recorded
Phase 1
NCT02616965 Feb 2017 → Aug 2022 primary cutaneous T-cell lymphoma Fox Chase Cancer Center
Completed
No outcome recorded
Phase 1
NCT02757248 Nov 2016 primary cutaneous T-cell lymphoma Anne Beaven, MD
Withdrawn
No outcome recorded
Phase 1
NCT02783625 May 2016 → Apr 2026 T-cell non-Hodgkin lymphoma Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 1
NCT02512172 Feb 2016 → Nov 2021 colorectal cancer Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Completed
No outcome recorded
Phase 1
NCT02616874 Feb → Sep 2016 HIV infectious disease IrsiCaixa
Completed
No outcome recorded
Phase 1
NCT02181218 Feb 2015 → Mar 2019 Hodgkins lymphoma , diffuse large B-cell lymphoma , peripheral T-cell lymphoma, not otherwise specified , primary cutaneous T-cell lymphoma Washington University School of Medicine
Completed
No outcome recorded
Phase 1
NCT01902225 Mar 2014 → Jul 2018 T-cell non-Hodgkin lymphoma Weiyun Ai
Completed
No outcome recorded
Phase 1
NCT01846390 Oct 2013 → Jul 2016 diffuse large B-cell lymphoma , peripheral T-cell lymphoma, not otherwise specified Canadian Cancer Trials Group
Completed
No outcome recorded
Phase 1
NCT01897012 Jul 2013 → Oct 2018 Burkitt lymphoma , Hodgkins lymphoma , diffuse large B-cell lymphoma , follicular lymphoma +3 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01738594 Mar 2013 → Oct 2016 mycosis fungoides and variants , primary cutaneous T-cell non-Hodgkin lymphoma Northwestern University
Terminated
No outcome recorded
Phase 1
NCT01742793 Oct 2012 → Aug 2016 Hodgkins lymphoma , mature T-cell and NK-cell non-Hodgkin lymphoma , plasma cell myeloma Yale University
Terminated
No outcome recorded
Phase 1
NCT01638533 Aug 2012 → Nov 2018 breast carcinoma , chronic lymphocytic leukemia/small lymphocytic lymphoma , colorectal carcinoma , cutaneous melanoma +12 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT01537744 Feb 2012 → Mar 2016 cancer , virus associated tumor Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Completed
No outcome recorded
Phase 1
NCT01324310 Apr 2011 → Jan 2012 lymphoma Celgene Corporation
Completed
No outcome recorded
Phase 1
NCT01324323 Apr 2011 → Feb 2012 lymphoma Celgene Corporation
Completed
No outcome recorded
Phase 1
NCT00963274 Apr 2010 → Jul 2014 leukemia , lymphoma Virginia Commonwealth University
Completed
No outcome recorded
Phase 1
NCT01302808 Sep 2009 → Dec 2014 lung cancer , metastatic malignant neoplasm University of Texas Southwestern Medical Center
Completed
No outcome recorded
Phase 1
NCT01445340 Apr 2007 → Jun 2012 mycosis fungoides National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1
NCT00379639 Jul 2006 → Jul 2008 malignant pancreatic neoplasm Celgene Corporation
Completed
No outcome recorded
Phase 1
NCT00114257 May 2005 → Sep 2006 leukemia , myelodysplastic syndrome , myelodysplastic/myeloproliferative neoplasm National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00094978 Oct 2004 → May 2013 esophageal cancer , malignant pleural mesothelioma , non-small cell lung carcinoma , small cell carcinoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 1
NCT00048334 Oct 2002 → Apr 2010 neoplasm National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00053963 Sep 2002 → Feb 2006 B-cell chronic lymphocytic leukemia , blast phase chronic myelogenous leukemia, BCR-ABL1 positive , childhood acute lymphoblastic leukemia , childhood acute myeloid leukemia +14 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00037817 May 2002 → Oct 2008 esophageal cancer , non-small cell lung carcinoma , pleural mesothelioma , small cell lung carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 1
NCT00024180 Jan 2002 → Aug 2006 leukemia , lymphoma Ohio State University Comprehensive Cancer Center
Completed
No outcome recorded
Phase 1
NCT00019318 Aug 1997 → ? lymphoma National Cancer Institute (NCI)
Completed
No outcome recorded
Show 24 more trials Phase 1/2 21 trials
Phase 1/2
NCT04257448 May 2020 → Jul 2024 pancreatic ductal adenocarcinoma GWT-TUD GmbH
Completed
No outcome recorded
Phase 1/2
NCT03770000 Mar 2019 → May 2021 T-cell non-Hodgkin lymphoma Rhizen Pharmaceuticals SA
Completed
No outcome recorded
Phase 1/2
NCT03547700 Sep 2018 → Aug 2020 peripheral T-cell lymphoma, not otherwise specified University of Michigan Rogel Cancer Center
Terminated
No outcome recorded
Phase 1/2
NCT03161223 May 2018 → Feb 2023 overdue T-cell non-Hodgkin lymphoma University of Virginia
Recruiting
No outcome recorded
Phase 1/2
NCT03278782 Nov 2017 → Jul 2027 expected anaplastic large cell lymphoma , angioimmunoblastic T-cell lymphoma , mycosis fungoides , peripheral T-cell lymphoma, not otherwise specified M.D. Anderson Cancer Center
Active not recruiting
No outcome recorded
Phase 1/2
NCT02281279 Oct 2016 → Oct 2020 B-cell adult acute lymphocytic leukemia , Burkitt lymphoma , MALT lymphoma , Waldenstrom macroglobulinemia +10 Mayo Clinic
Withdrawn
No outcome recorded
Phase 1/2
NCT02393794 Jul 2015 → Jul 2026 overdue triple-negative breast carcinoma Priyanka Sharma
Active not recruiting
No outcome recorded
Phase 1/2
NCT03141203 Jul 2015 → Aug 2020 peripheral T-cell lymphoma, not otherwise specified University of Birmingham
Completed
No outcome recorded
Phase 1/2
NCT02341014 Jan 2015 → Jan 2023 T-cell non-Hodgkin lymphoma Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 1/2
NCT02223208 Sep 2014 → Oct 2020 overdue ALK-negative anaplastic large cell lymphoma , Nodal T-follicular helper cell lymphoma, follicular type , angioimmunoblastic T-cell lymphoma , peripheral T-cell lymphoma, not otherwise specified Fondazione Italiana Linfomi - ETS
Active not recruiting
No outcome recorded
Phase 1/2
NCT01933594 May 2014 → Apr 2018 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID)
Completed
No outcome recorded
Phase 1/2
NCT01938833 Apr 2014 → Aug 2016 Her2-receptor negative breast cancer , inflammatory breast carcinoma , male breast carcinoma Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
Terminated
No outcome recorded
Phase 1/2
NCT02092116 Mar 2014 → Aug 2015 HIV infectious disease Bionor Immuno AS
Completed
No outcome recorded
Phase 1/2
NCT01979276 Nov 2013 → Oct 2016 plasma cell myeloma Weill Medical College of Cornell University
Terminated
No outcome recorded
Phase 1/2
NCT01998035 Nov 2013 → Jan 2020 Hodgkins lymphoma , non-Hodgkin lymphoma Columbia University
Terminated
No outcome recorded
Phase 1/2
NCT01947140 Sep 2013 → Sep 2022 Hodgkins lymphoma , non-Hodgkin lymphoma , plasma cell myeloma Jennifer Amengual
Completed
No outcome recorded
Phase 1/2
NCT01755975 Dec 2012 → Oct 2023 non-Hodgkin lymphoma , plasma cell myeloma Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 1/2
NCT01456039 Dec 2011 → Jul 2015 peripheral T-cell lymphoma, not otherwise specified Celgene Corporation
Completed
No outcome recorded
Phase 1/2
NCT01280526 Jan 2011 → Nov 2012 peripheral T-cell lymphoma, not otherwise specified The Lymphoma Academic Research Organisation
Completed
No outcome recorded
Phase 1/2
NCT00431990 Nov 2006 → Dec 2011 plasma cell myeloma Peter MacCallum Cancer Centre, Australia
Unknown
No outcome recorded
Phase 1/2
NCT00085540 Jan 2005 → Dec 2008 anaplastic astrocytoma , anaplastic oligodendroglioma , giant cell glioblastoma , gliosarcoma National Cancer Institute (NCI)
Completed
No outcome recorded
Show 11 more trials Phase 2 34 trials
Phase 2
NCT04747236 Feb 2021 → Jun 2028 expected —
University of Virginia
Recruiting
No outcome recorded
Phase 2
NCT03534180 Aug 2018 → Apr 2021 anaplastic large cell lymphoma City of Hope Medical Center
Completed
No outcome recorded
Phase 2
NCT02788201 Mar 2017 → Oct 2019 urinary bladder cancer , urothelial carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT02850016 Jan 2017 → Dec 2020 HIV infectious disease Rockefeller University
Completed
No outcome recorded
Phase 2
NCT02232516 Jun 2015 → Aug 2020 anaplastic large cell lymphoma , angioimmunoblastic T-cell lymphoma , extranodal nasal NK/T cell lymphoma , hepatosplenic T-cell lymphoma +2 Northwestern University
Completed
No outcome recorded
Phase 2
NCT01822886 Jan 2013 → Dec 2014 peripheral T-cell lymphoma, not otherwise specified Fondazione Italiana Linfomi - ETS
Completed
No outcome recorded
Phase 2
NCT01353664 May 2011 → Sep 2012 cancer , lymphoma Celgene Corporation
Completed
No outcome recorded
Phase 2
NCT00765102 Sep 2008 → Mar 2010 plasma cell myeloma Celgene Corporation
Terminated
No outcome recorded
Phase 2
NCT00426764 Jun 2007 → Nov 2010 peripheral T-cell lymphoma, not otherwise specified Celgene Corporation
Completed
No outcome recorded
Phase 2
NCT00383565 Sep 2006 → Apr 2011 diffuse large B-cell lymphoma , mantle cell lymphoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 2
NCT00104884 Oct 2005 → May 2006 melanoma ECOG-ACRIN Cancer Research Group
Terminated
No outcome recorded
Phase 2
NCT00084682 Jun 2005 → Nov 2008 hypopharynx squamous cell carcinoma , laryngeal squamous cell carcinoma , lip and oral cavity squamous cell carcinoma , oropharynx squamous cell carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00085527 May → Sep 2005 ovarian cancer University of Chicago
Withdrawn
No outcome recorded
Phase 2
NCT00098397 Feb → Sep 2005 male breast carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00112463 Jan 2005 → Oct 2008 Ewing sarcoma/peripheral primitive neuroectodermal tumor , adult epithelioid sarcoma , adult extraskeletal osteosarcoma , adult fibrosarcoma +12 National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00106431 Jan 2005 → Jun 2008 primary cutaneous T-cell lymphoma Celgene Corporation
Completed
No outcome recorded
Phase 2
NCT00098813 Oct 2004 → Aug 2009 thyroid gland follicular carcinoma , thyroid gland papillary carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00098527 Oct 2004 → Sep 2005 esophageal adenocarcinoma , gastric adenocarcinoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 2
NCT00091195 Sep 2004 → Mar 2007 malignant epithelial tumor of ovary , peritoneum cancer National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 2
NCT00087295 Jun 2004 → Apr 2006 renal pelvis/ureter urothelial carcinoma , urethra cancer , urinary bladder cancer SWOG Cancer Research Network
Terminated
No outcome recorded
Phase 2
NCT00086827 May 2004 → Nov 2006 small cell lung carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00106301 Apr 2004 → Sep 2006 prostate cancer , renal cell carcinoma Celgene Corporation
Completed
No outcome recorded
Phase 2
NCT00077337 Apr 2004 → Apr 2006 colorectal cancer SWOG Cancer Research Network
Completed
No outcome recorded
Phase 2
NCT00084461 Mar → Oct 2004 PPoma , gastrin-producing neuroendocrine tumor , glucagonoma , lung carcinoid tumor +3 National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 2
NCT00079443 Jan 2004 → Sep 2005 chronic lymphocytic leukemia/small lymphocytic lymphoma National Cancer Institute (NCI)
Terminated
No outcome recorded
Phase 2
NCT00077194 Jan 2004 → Dec 2005 lymphoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00066638 Jun 2003 → May 2007 plasma cell myeloma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00106418 May 2003 → Sep 2006 metastatic neoplasm , prostate cancer Celgene Corporation
Completed
No outcome recorded
Phase 2
NCT00106613 May 2003 → Aug 2004 metastatic neoplasm , renal cell carcinoma Celgene Corporation
Completed
No outcome recorded
Phase 2
NCT00062075 May 2003 → Mar 2007 acute myeloid leukemia with 11q23 abnormalities , acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22) , acute myeloid leukemia with t(8;21)(q22;q22) translocation , acute promyelocytic leukemia National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00042822 May 2002 → Mar 2005 leukemia , lymphoma , myelodysplastic syndrome , myelodysplastic/myeloproliferative neoplasm Memorial Sloan Kettering Cancer Center
Completed
No outcome recorded
Phase 2
NCT00007345 Mar 2001 → Jan 2015 peripheral T-cell lymphoma, not otherwise specified , primary cutaneous T-cell lymphoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00020202 Jun 2000 → Mar 2007 non-small cell lung carcinoma , small cell lung carcinoma National Cancer Institute (NCI)
Completed
No outcome recorded
Phase 2
NCT00299351 — peripheral T-cell lymphoma, not otherwise specified Royal Marsden NHS Foundation Trust
Unknown
No outcome recorded
Show 24 more trials Phase 3 2 trials
Phase 3
NCT03355768 Sep → Nov 2018 peripheral T-cell lymphoma, not otherwise specified Jennifer Amengual
Withdrawn
No outcome recorded
Phase 3
NCT01796002 Jan 2013 → Dec 2019 peripheral T-cell lymphoma, not otherwise specified The Lymphoma Academic Research Organisation
Completed
No outcome recorded
Phase not applicable 2 trials
— NCT02551718 Sep 2015 → Jun 2020 acute leukemia of ambiguous lineage , acute lymphoblastic leukemia University of Washington
Completed
No outcome recorded
— NCT02203578 Nov 2014 → Jun 2016 graft versus host disease Rutgers, The State University of New Jersey
Terminated
No outcome recorded